Nuveen
EBS icon

Nuveen’s Emergent Biosolutions EBS Stock Holding History

Nuveen’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,700
Closed -$1K – 3313
2022
Q1 		$1K Buy
+29,700
New +$1.31M ﹤0.01% 3380
2021
Q4 		– Sell
-47,600
Closed -$2K – 3350
2021
Q3 		$2K Buy
+47,600
New +$2.88M ﹤0.01% 3408
2021
Q2 		– Sell
-45,800
Closed -$4K – 3410
2021
Q1 		$4K Buy
+45,800
New +$4.69M ﹤0.01% 3340

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Nuveen's EBS Position: Q2 2026 in Review

Nuveen increased its Emergent Biosolutions (EBS) stake by 7.8% in Q2 2026, buying an estimated $69.3K and bringing the position to 114,334 shares worth $958K. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

Nuveen first reported a position in EBS in Q2 2015 and has held it in 41 quarters since. The position peaked at $37.8M in Q1 2021. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Nuveen held 114,334 shares of Emergent Biosolutions worth $958K as of Q2 2026.
  • Nuveen bought 8,287 Emergent Biosolutions shares in Q2 2026, an estimated $69.3K.
  • Emergent Biosolutions made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2958 holding.
  • Nuveen first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 41 quarters since.
  • Nuveen's Emergent Biosolutions position peaked at $37.8M in Q1 2021.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.